Consensus validation of a screening tool for cardiovascular pharmacotherapy in geriatric patients: the RASP_CARDIO list (Rationalization of Home Medication by an Adjusted STOPP list in Older Patients).
Cardiovascular agents
Delphi technique
Geriatrics
Inappropriate prescribing
Medication review
Journal
European geriatric medicine
ISSN: 1878-7649
Titre abrégé: Eur Geriatr Med
Pays: Switzerland
ID NLM: 101533694
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
30
06
2022
accepted:
26
09
2022
pubmed:
14
10
2022
medline:
30
12
2022
entrez:
13
10
2022
Statut:
ppublish
Résumé
Cardiovascular agents commonly used in geriatric patients, are linked to potentially avoidable harm and might hence be a suitable substrate for medication review practices. Therefore, we sought to update and validate the content of the cardiovascular segment of the previously published Rationalization of Home Medication by an Adjusted STOPP list in Older Patients (RASP) List. A three-step study was conducted by the pharmacy department in collaboration with the geriatric medicine and cardiology department at the University Hospitals Leuven, Belgium. First, the cardiovascular segment of the RASP list version 2014 was updated taking into account published research, other screening tools and the input of end-users. Secondly, this draft was reviewed during three panel discussions with five expert cardiologists and three clinical pharmacists, all of whom had relevant expertise in geriatric pharmacotherapy. Thirdly, the content was validated using a modified Delphi Technique by a panel of European hospital pharmacists, cardiologists, geriatricians and an internal medicine physician. After the first and second step, the RASP_CARDIO list comprised 94 statements. Consensus (≥ 80% agreement) of all statements and one new statement about gliflozins in heart failure was achieved by a panel of seventeen experts across four European countries after two validation rounds. The final construct comprised a list of 95 statements related to potentially inappropriate prescribing of cardiovascular agents. The RASP_CARDIO list is an updated and validated explicit screening tool to optimize cardiovascular pharmacotherapy in geriatric patients.
Identifiants
pubmed: 36229756
doi: 10.1007/s41999-022-00701-w
pii: 10.1007/s41999-022-00701-w
doi:
Substances chimiques
Cardiovascular Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1467-1476Informations de copyright
© 2022. The Author(s), under exclusive licence to European Geriatric Medicine Society.
Références
Lopez-Rodriguez JA, Rogero-Blanco E, Aza-Pascual-Salcedo M, Lopez-Verde F, Pico-Soler V, Leiva-Fernandez F et al (2020) Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: a cross-sectional study. PLoS ONE 15(8):e0237186
doi: 10.1371/journal.pone.0237186
Cooper JA, Cadogan CA, Patterson SM, Kerse N, Bradley MC, Ryan C et al (2015) Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review. BMJ Open 5(12):e009235
doi: 10.1136/bmjopen-2015-009235
Mugada V, Bhagavathi KC, Sagina P, Karnataka K, Ravada S, Kancharapu RM (2021) Potentially inappropriate medications, drug-drug interactions, and prescribing practices in elderly patients: a cross-sectional study. Rev Assoc Med Bras 67(6):800–805
doi: 10.1590/1806-9282.20200912
Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D et al (2015) Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med 175(5):827–834
doi: 10.1001/jamainternmed.2015.0324
Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C et al (2007) Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370(9582):173–184
doi: 10.1016/S0140-6736(07)61091-5
Van der Linden L (2018) Improving drug use in older adults during hospital stay. 1–220
Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K (2015) Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol 71(12):1415–1427
doi: 10.1007/s00228-015-1954-4
Gallagher PF, O’Connor MN, O’Mahony D (2011) Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 89(6):845–854
doi: 10.1038/clpt.2011.44
Mertens B, Hias J, Hellemans L, Walgraeve K, Spriet I, Tournoy J et al (2022) Drug-related hospital admissions in older adults: comparison of the Naranjo algorithm and an adjusted version of the Kramer algorithm. Eur Geriatr Med 13(3):567–577
doi: 10.1007/s41999-022-00623-7
Artikel II van het Koninklijk Besluit houdende vaststelling eensdeels, van de normen waaraan het zorgprogramma voor de geriatrische patiënt moet voldoen om te worden erkend en, anderdeels, van bijzondere aanvullende normen voor de erkenning van ziekenhuizen en ziekenhuisdiensten, 2007 ( http://www.ejustice.just.fgov.be/eli/besluit/2007/01/29/2007022208/justel )
Aguiar JP, Marques JG (2021) Utility and limitations of a screening tool of older person’s prescription among psychiatric elder patients: a comprehensive review. Aging Health Res. 1(3):100031
doi: 10.1016/j.ahr.2021.100031
Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM, Group HS (2008) Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 168(17):1890–1896
Lavan AH, Gallagher PF, O’Mahony D (2016) Methods to reduce prescribing errors in elderly patients with multimorbidity. Clin Interv Aging 11:857–866
Onder G, Landi F, Fusco D, Corsonello A, Tosato M, Battaglia M et al (2014) Recommendations to prescribe in complex older adults: results of the CRIteria to assess appropriate medication use among elderly complex patients (CRIME) project. Drugs Aging 31(1):33–45
doi: 10.1007/s40266-013-0134-4
Wehling M (2011) Guideline-driven polypharmacy in elderly, multimorbid patients is basically flawed: there are almost no guidelines for these patients. J Am Geriatr Soc 59(2):376–377
doi: 10.1111/j.1532-5415.2011.03252.x
Cherubini A, Oristrell J, Pla X, Ruggiero C, Ferretti R, Diestre G et al (2011) The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med 171(6):550–556
doi: 10.1001/archinternmed.2011.31
Raza JA, Movahed A (2002) Use of cardiovascular medications in the elderly. Int J Cardiol 85(2):203–215
doi: 10.1016/S0167-5273(02)00193-6
Walgraeve K, Van der Linden L, Flamaing J, Fagard K, Spriet I, Tournoy J (2018) Feasibility of optimizing pharmacotherapy in heart failure patients admitted to an acute geriatric ward: role of the clinical pharmacist. Eur Geriatr Med 9(1):103–111
doi: 10.1007/s41999-017-0019-x
Ayan M, Pothineni NV, Siraj A, Mehta JL (2016) Cardiac drug therapy-considerations in the elderly. J Geriatr Cardiol 13(12):992–997
Van Der Linden L, Hias J, Walgraeve K, Loyens S, Flamaing J, Spriet I et al (2021) Factors associated with the number of clinical pharmacy recommendations: findings from an observational study in geriatric inpatients. Acta Clin Belg 76(2):119–126
doi: 10.1080/17843286.2019.1683128
Morabet NE, Uitvlugt EB, van den Bemt BJF, van den Bemt PMLA, Janssen MJA et al (2018) Prevalence and preventability of drug-related hospital readmissions: a systematic review. J Am Geriatric Soc 66(3):602–608
doi: 10.1111/jgs.15244
Ravn-Nielsen LV, Duckert ML, Lund ML, Henriksen JP, Nielsen ML, Eriksen CS et al (2018) Effect of an in-hospital multifaceted clinical pharmacist intervention on the risk of readmission: a randomized clinical trial. JAMA Intern Med 178(3):375–382
doi: 10.1001/jamainternmed.2017.8274
Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H et al (2009) A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med 169(9):894–900
doi: 10.1001/archinternmed.2009.71
O'Mahony D, Gudmundsson A, Soiza RL, Petrovic M, Jose Cruz-Jentoft A, Cherubini A, Fordham R, Byrne S, Dahly D, Gallagher P, Lavan A, Curtin D, Dalton K, Cullinan S, Flanagan E, Shiely F, Samuelsson O, Sverrisdottir A, Subbarayan S, Vandaele L, Meireson E, Montero-Errasquin B, Rexach-Cano A, Correa Perez A, Lozano-Montoya I, Vélez-Díaz-Pallarés M, Cerenzia A, Corradi S, Soledad Cotorruelo Ferreiro M, Dimitri F, Marinelli P, Martelli G, Fong Soe Khioe R, Eustace J (2020) Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial. Age Ageing 49(4):605–614
doi: 10.1093/ageing/afaa072
Blum M R, Sallevelt B T G M, Spinewine A, O'Mahony D, Moutzouri E, Feller M et al (2021) Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial BMJ 374:n1585
doi: 10.1136/bmj.n1585
Dautzenberg L, Bretagne L, Koek HL, Tsokani S, Zevgiti S, Rodondi N et al (2021) Medication review interventions to reduce hospital readmissions in older people. J Am Geriatr Soc 69(6):1646–1658
doi: 10.1111/jgs.17041
Kempen T, Bertilsson M, Hadziosmanovic N, Lindner K, Melhus H, Nielsen E, Sulku J, Gillespie U (2021) Effects of hospital-based comprehensive medication reviews including postdischarge follow-up on older patients’ use of health care: a cluster randomized clinical trial. JAMA Netw Open 4(4):e216303
doi: 10.1001/jamanetworkopen.2021.6303
Petrovic M, Somers A, Onder G (2016) Optimization of geriatric pharmacotherapy: role of multifaceted cooperation in the hospital setting. Drugs Aging 33(3):179–188
doi: 10.1007/s40266-016-0352-7
Counter D, Millar JWT, McLay JS (2018) Hospital readmissions, mortality and potentially inappropriate prescribing: a retrospective study of older adults discharged from hospital. Br J Clin Pharmacol 84(8):1757–1763
doi: 10.1111/bcp.13607
Van der Linden L, Decoutere L, Walgraeve K, Milisen K, Flamaing J, Spriet I et al (2017) Combined use of the rationalization of home medication by an adjusted STOPP in older patients (RASP) list and a pharmacist-led medication review in very old inpatients: impact on quality of prescribing and clinical outcome. Drugs Aging 34(2):123–133
doi: 10.1007/s40266-016-0424-8
Van der Linden L, Hias J, Walgraeve K, Flamaing J, Tournoy J, Spriet I (2020) Clinical pharmacy services in older inpatients: an evidence-based review. Drugs Aging 37(3):161–174
doi: 10.1007/s40266-019-00733-1
Lavan AH, Gallagher P, Parsons C, O’Mahony D (2017) STOPPFrail (screening tool of older persons prescriptions in frail adults with limited life expectancy): consensus validation. Age Ageing 46(4):600–607
Van der Linden L, Decoutere L, Flamaing J, Spriet I, Willems L, Milisen K et al (2014) Development and validation of the RASP list (Rationalization of Home Medication by an Adjusted STOPP list in Older Patients): a novel tool in the management of geriatric polypharmacy. Eur Geriatr Med 5(3):175–180
doi: 10.1016/j.eurger.2013.12.005
Van der Linden L, Hias J, Dreessen L, Milisen K, Flamaing J, Spriet I et al (2018) Medication review versus usual care to improve drug therapies in older inpatients not admitted to geriatric wards: a quasi-experimental study (RASP-IGCT). BMC Geriatr 18(1):155
doi: 10.1186/s12877-018-0843-y
Van der Linden L, Decoutere L, Beerten L, Delva T, Spriet I, Flamaing J et al (2019) External validation of a clinical pharmacy intervention in geriatric inpatients: a controlled study. Int J Clin Pharm 41(4):853–858
doi: 10.1007/s11096-019-00846-y
Fick DM, Semla TP, Steinman M, Beizer J, Brandt N, Dombrowski R et al (2019) American Geriatrics Society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc 67(4):674–694
doi: 10.1111/jgs.15767
O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P (2015) STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44(2):213–218
doi: 10.1093/ageing/afu145
Stewart D, Gibson-Smith K, MacLure K, Mair A, Alonso A, Codina C et al (2017) A modified Delphi study to determine the level of consensus across the European union on the structures, processes and desired outcomes of the management of polypharmacy in older people. PLoS ONE 12(11):e0188348
doi: 10.1371/journal.pone.0188348
Hutchings A, Raine R, Sanderson C, Black N (2006) A comparison of formal consensus methods used for developing clinical guidelines. J Health Serv Res Policy 11(4):218–224
doi: 10.1258/135581906778476553
Hias J, Van der Linden L, Walgraeve K, Lemper JC, Hellemans L, Spriet I, Tournoy J (2022) Optimizing pharmacotherapy on geriatric hospital units in Belgium - a national survey. Acta Clin Belg 77(2):321–328
doi: 10.1080/17843286.2020.1864162
Hsu C-C, Sandford BA (2007) The Delphi technique: making sense of consensus: pract assessment. Res Eval 12(10):1–8
Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP et al (2019) Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. N Engl J Med 381(17):1609–1620
doi: 10.1056/NEJMoa1908655
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C et al (2020) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42(5):373–498
doi: 10.1093/eurheartj/ehaa612
Curtin D, Gallagher PF, O’Mahony D (2019) Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences. Ther Adv Drug Saf 10:2042098619829431.
doi: 10.1177/2042098619829431
Nexus. Nexus Hospitals 2021 [Available from: https://www.nexushospitals.com.au/ . Accessed 12 Sept 2022
Quintens C, Verhamme P, Vanassche T, Vandenbriele C, Van den Bosch B, Peetermans WE et al (2022) Improving appropriate use of anticoagulants in hospitalised patients: A pharmacist-led Check of Medication Appropriateness intervention. Br J Clin Pharmacol 88(6):2959–2968
doi: 10.1111/bcp.15184
McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381(21):1995–2008
doi: 10.1056/NEJMoa1911303
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P et al (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 383(15):1413–1424
doi: 10.1056/NEJMoa2022190
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M et al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 42(36):3599–3726
doi: 10.1093/eurheartj/ehab368
Aggarwal P, Woolford SJ, Patel HP (2020) Multi-morbidity and polypharmacy in older people: challenges and opportunities for clinical practice. Geriatrics (Basel) 5(4):85
doi: 10.3390/geriatrics5040085
Quintens C, De Rijdt T, Van Nieuwenhuyse T et al (2019) Development and implementation of “Check of Medication Appropriateness” (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillance. BMC Med Inform Decis Mak 19:29
doi: 10.1186/s12911-019-0748-5
Ivanova I, Elseviers M, Wauters M, Christiaens T, Vander SR (2018) European repository of explicit criteria of potentially inappropriate medications in old age. Geriatr Gerontol Int 18(8):1293–1297
doi: 10.1111/ggi.13331
Hias J, Hellemans L, Laenen A, Walgraeve K, Liesenborghs A, De Geest S, Luyten J, Spriet I, Flamaing J, Van der Linden L, Tournoy J (2022) The effect of a trAnSitional Pharmacist Intervention in geRiatric inpatients on hospital visits after dischargE (ASPIRE): Protocol for a randomized controlled trial. Contemp Clin Trials 119:106853
doi: 10.1016/j.cct.2022.106853